Sangamo Therapeutics Inc (SGMO) — Cash Flow Reinvestment Rate
Sangamo Therapeutics Inc (SGMO) has a Cash Flow Reinvestment Rate of 0.03x as of September 2024, reinvesting $348.00K (capex $115.00K plus investments $233.00K) from operating cash flow of $11.76 Million. See SGMO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Sangamo Therapeutics Inc Cash Flow Reinvestment Rate (2017–2020)
Historical reinvestment intensity for Sangamo Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see Sangamo Therapeutics Inc (SGMO) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Sangamo Therapeutics Inc (2017–2020)
Year-by-year capital reinvestment analysis for Sangamo Therapeutics Inc. See financial agility of Sangamo Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.59x | $270.92 Million | $169.88 Million | $14.71 Million | ▼ -42.2% |
| 2018 | 2.76x | $102.46 Million | $37.15 Million | $43.06 Million | ▼ -60.2% |
| 2017 | 6.92x | $77.40 Million | $11.18 Million | $3.75 Million | — |